ADVM: SEC Form SC 13D/A filed by Adverum Biotechnologies Inc. (Amendment)
Stocks in this Quantisnow insightHealth Care
Keep researching ADVM
- What is Schedule 13D?The SEC disclosure an investor must file after acquiring more than 5% of a company's voting stock with an active intent, such as seeking change.
- Schedule 13D vs 13GSchedule 13D vs 13G explained: who must file when crossing 5% ownership, the 2024 deadlines, how activists differ from passive holders, and what Item 4 reveals.
Quantisnow market dataNASDAQ
ADVM
Adverum Biotechnologies Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2014
Get push alerts for ADVM
Full ADVM profile on Quantisnow Follow ADVM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time